Normal serum uric acid gout: a neglected and challenging condition
Open Access
- 11 June 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1873856
Abstract
During acute gout flares, serum uric acid (SUA) levels may remain within the normal range, making diagnosis based solely on SUA unreliable. A systematic evaluation incorporating clinical symptoms and imaging (ultrasound, dual-source CT) is essential to detect monosodium urate (MSU) crystal deposition. Normal-SUA gout often presents with more pronounced inflammation, fever, elevated white blood cell count and C-reactive protein, and may occur after surgery or hemodialysis. Tophi can appear at typical or atypical sites (e.g., face, neck). No specific treatment guidelines exist, but lowering SUA to <360 μmol/L (6 mg/dl) reduces gout flares and promotes MSU dissolution. Emerging therapies—including anti-IL-1β monoclonal antibodies, NLRP3 inhibitors, uricases, and green tea components—show promise in controlling attacks and dissolving crystals without affecting SUA levels.Keywords
This publication has 52 references indexed in Scilit:
- Treatment Guidelines in GoutRheumatic Disease Clinics of North America, 2022
- Management of hyperuricemia in asymptomatic patients: A critical appraisalEuropean Journal of Internal Medicine, 2020
- Febuxostat in the treatment of gout patients with low serum uric acid level: 1-year finding of efficacy and safety studyClinical Rheumatology, 2018
- Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout StudyArthritis & Rheumatology, 2018
- Nasal gouty tophus: Report a rare case presenting as a nasal hump with nasal obstructionBiomedical Journal, 2016
- Gouty Arthritis: A Review of Acute Management and PreventionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Epigallocatechin gallate inhibits urate crystals‐induced peritoneal inflammation in C57BL/6 miceMolecular Nutrition & Food Research, 2016
- High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine studyArthritis & Rheumatism, 2010
- Ultrasonography for diagnosing atypical gout. Two case reportsJoint Bone Spine, 2008
- Epidemiology of gout and hyperuricemiaThe American Journal of Medicine, 1967